These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 17713121)

  • 21. Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of life.
    Snider BJ; Norton J; Coats MA; Chakraverty S; Hou CE; Jervis R; Lendon CL; Goate AM; McKeel DW; Morris JC
    Arch Neurol; 2005 Dec; 62(12):1821-30. PubMed ID: 16344340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction between Parkin and
    Madsen DA; Schmidt SI; Blaabjerg M; Meyer M
    Cells; 2021 Jan; 10(2):. PubMed ID: 33572534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetics of Parkinson's disease.
    Gasser T
    J Neurol; 2001 Oct; 248(10):833-40. PubMed ID: 11697518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on the genetics of Parkinson's disease.
    Gasser T
    Mov Disord; 2007 Sep; 22 Suppl 17():S343-50. PubMed ID: 18175395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A 73-year-old woman with familial Parkinson's disease].
    Takanashi M; Urabe T; Ohta S; Hamano Y; Mori H; Shirai T; Kondo T; Mizuno Y
    No To Shinkei; 1999 Dec; 51(12):1087-96. PubMed ID: 10654309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study of Parkinson's disease based on Drosophila model].
    Liang J; Luo J; Jin J
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 Nov; 42(6):685-92. PubMed ID: 24421238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery.
    Lee VM; Trojanowski JQ
    Neuron; 2006 Oct; 52(1):33-8. PubMed ID: 17015225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The genetics of Parkinson syndrome].
    Klein C
    Praxis (Bern 1994); 2001 Jun; 90(23):1015-23. PubMed ID: 11447721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ubiquitination of alpha-synuclein by Siah-1 promotes alpha-synuclein aggregation and apoptotic cell death.
    Lee JT; Wheeler TC; Li L; Chin LS
    Hum Mol Genet; 2008 Mar; 17(6):906-17. PubMed ID: 18065497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Relationship between alpha-synuclein and Parkinson's disease].
    Nishioka K; Hattori N
    Brain Nerve; 2007 Aug; 59(8):825-30. PubMed ID: 17713118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inclusion body formation and neurodegeneration are parkin independent in a mouse model of alpha-synucleinopathy.
    von Coelln R; Thomas B; Andrabi SA; Lim KL; Savitt JM; Saffary R; Stirling W; Bruno K; Hess EJ; Lee MK; Dawson VL; Dawson TM
    J Neurosci; 2006 Apr; 26(14):3685-96. PubMed ID: 16597723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TRAF6 promotes atypical ubiquitination of mutant DJ-1 and alpha-synuclein and is localized to Lewy bodies in sporadic Parkinson's disease brains.
    Zucchelli S; Codrich M; Marcuzzi F; Pinto M; Vilotti S; Biagioli M; Ferrer I; Gustincich S
    Hum Mol Genet; 2010 Oct; 19(19):3759-70. PubMed ID: 20634198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progress in the clinical and molecular genetics of familial parkinsonism.
    Kitada T; Asakawa S; Matsumine H; Hattori N; Shimura H; Minoshima S; Shimizu N; Mizuno Y
    Neurogenetics; 2000 Mar; 2(4):207-18. PubMed ID: 10983716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Advances in the genetic studies in Parkinson's disease].
    Krygowska-Wajs A; Wszolek Z
    Neurol Neurochir Pol; 2004; 38(2):127-36. PubMed ID: 15307606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Autosomal recessive juvenile parkinsonism: its pathogenesis is involved in the ubiquitin-proteasome pathway].
    Hattori N; Shimura H; Kubo S; Suzuki T; Tanaka K; Mizuno Y
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1293-6. PubMed ID: 11464483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical genetics of Parkinson's disease and related disorders.
    Wider C; Wszolek ZK
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S229-32. PubMed ID: 18267241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ubiquitin-proteasome system and Parkinson's diseases.
    Betarbet R; Sherer TB; Greenamyre JT
    Exp Neurol; 2005 Feb; 191 Suppl 1():S17-27. PubMed ID: 15629758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical, neuropathological and genotypic variability in SNCA A53T familial Parkinson's disease. Variability in familial Parkinson's disease.
    Markopoulou K; Dickson DW; McComb RD; Wszolek ZK; Katechalidou L; Avery L; Stansbury MS; Chase BA
    Acta Neuropathol; 2008 Jul; 116(1):25-35. PubMed ID: 18389263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson's disease.
    McNaught KS; Olanow CW
    Ann Neurol; 2003; 53 Suppl 3():S73-84; discussion S84-6. PubMed ID: 12666100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.